Overproduction of low density lipoproteins associated with coronary heart disease

Area of Science:

• Cardiovascular Science
• Metabolic Research
• Lipid Metabolism

Background:

• Coronary heart disease (CHD) is a leading cause of mortality.
• Understanding lipoprotein metabolism is crucial for CHD management.
• Apolipoprotein B (apoB) containing lipoproteins, like LDL, are key players in atherogenesis.

Purpose of the Study:

• To investigate apolipoprotein LDL (apoLDL) turnover rates in men with CHD.
• To compare apoLDL synthesis and catabolism between CHD patients and healthy controls.
• To explore the relationship between apoLDL kinetics and normocholesterolemia in CHD.

Main Methods:

• Determined apoLDL turnover rates in eight men with CHD and seven matched controls.
• Measured plasma lipid levels, LDL cholesterol, and apoLDL concentrations.
• Calculated apoLDL synthetic and fractional catabolic rates.

Main Results:

• CHD patients exhibited higher apoLDL synthetic rates (20.0 mg/kg/day) compared to controls (12.9 mg/kg/day).
• Despite increased synthesis, LDL and apoLDL levels were similar between groups due to a 43% higher fractional catabolic rate in CHD patients.
• LDL particles in CHD patients had a 19% higher protein-to-cholesterol ratio.

Conclusions:

• Patients with CHD can have altered apoLDL turnover, including overproduction and accelerated catabolism, even with normal LDL cholesterol levels.
• These kinetic abnormalities in apoLDL metabolism may contribute to the development of atherosclerosis.
• Further research into apoLDL dynamics is warranted for improved CHD risk assessment and therapeutic strategies.